Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with a drug company.
Pfizer has agreed to pay $35 million to resolve allegations by 42 states that a subsidiary illegally marketed an organ transplant drug for unapproved uses.
Jackley says the misleading claims put consumers' health at risk.
Authorities say Wyeth Pharmaceuticals, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Rapamune was approved in 1999 for use in kidney transplant patients. It's illegal to promote drugs for uses not cleared by the Food and Drug Administration.
Pfizer says the alleged activity occurred before it acquired Wyeth. The company didn't admit any wrongdoing or liability as part of the settlement.
Most Popular Today
- 1.Your Money Matters
$1.3 Million Loft For Sale In Downtown Sioux Falls
- 2.Health Care
South Dakota Is Among Worst States For Nurses
- 3.Your Money Matters, General
Inside New $1.3 Million Downtown Loft
- 4.Retail & Restaurants
Sally Beauty Investigating Unusual Card Activity
- 5.Health Care
Med-Star Picked To Be Minnehaha Co. Ambulance Provider
Sioux Falls Ranks As One Of The Cheapest Road Trips
Pandora To Purchase Rapid City Radio Station
- 8.Gas & Energy
New Hy-Vee Gas Station In Sioux Falls
Standard And Poor's Upgrades South Dakota's Credit Rating
FCC Clears Way For Pandora To Buy Rapid City Radio Station